Brief: Achilles Therapeutics Presents Data At The 2021 European Society For Gene And Cell Therapy (Esgct) Congress
22/10/2021 12:36
Oct 22 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS PRESENTS DATA AT THE 2021 EUROPEAN
SOCIETY
FOR GENE AND CELL THERAPY (ESGCT) CONGRESS DEMONSTRATING ITS
PROPRIETARY MANUFACTURING PROCESS CAN GENERATE POTENT,
PERSONALIZED ANTI-CANCER CELL THERAPY CANDIDATES IN MULTIPLE
SOLID TUMOR TYPES
Source text for Eikon: ID:nGNXVN3PW
Further company coverage: 698y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement